← Open Payments lookup

LYNDA ARTUSIO: Open Payments

NPI 1841363702 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$443 in 21 payments from 7 companies in 2025. Trend: 2023 $457 · 2024 $152 · 2025 $443

Food & beverage: $414Education: $29
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$166
Axsome Therapeutics, Inc.3$146
Otsuka America Pharmaceutical, Inc.3$46
Novo Nordisk Inc1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Alkermes, Inc.1$21
TOLMAR, INC.1$18

Products named: INGREZZA, Auvelity, REXULTI, Ozempic, CAPLYTA, ARISTADA, JATENZO.

Industry payments across MD — which companies pay providers there.